Company Filing History:
Years Active: 2008
Title: The Innovations of Harry W. Mandeville, III
Introduction
Harry W. Mandeville, III is an accomplished inventor based in Lynnfield, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of obesity. His innovative approach has led to the development of a unique compound that holds promise for effective obesity management.
Latest Patents
Mandeville holds a patent for "Aryl boronic acids for treating obesity." This patent discloses a phenyl boronic acid compound represented by Structural Formula (I). The invention includes a method of treating obesity in a subject by administering an effective amount of the compound along with a pharmaceutical composition that comprises the compound and a pharmaceutically acceptable carrier or diluent. He has 1 patent to his name.
Career Highlights
Mandeville is associated with Genzyme Corporation, a leading biotechnology company known for its innovative therapies. His work at Genzyme has allowed him to focus on developing solutions that address critical health issues, particularly obesity.
Collaborations
Some of his notable coworkers include Stephen Randall Holmes-Farley and Pradeep K. Dhal. Their collaboration has likely contributed to the advancement of research and development within their field.
Conclusion
Harry W. Mandeville, III exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the treatment of obesity, highlight the importance of research and collaboration in developing effective medical solutions.